Literature DB >> 23568902

Efficacy of antemortem rectal biopsies to diagnose and estimate prevalence of chronic wasting disease in free-ranging cow elk (Cervus elaphus nelsoni).

Ryan J Monello1, Jenny G Powers, N Thompson Hobbs, Terry R Spraker, Katherine I O'Rourke, Margaret A Wild.   

Abstract

A reliable antemortem test is needed to understand the ecology of chronic wasting disease (CWD) in elk (Cervus elaphus nelsoni). We measured the ability of antemortem biopsy samples from the rectal mucosa to detect the abnormal prion protein associated with CWD (PrP(CWD)), the relationship between test results from the obex and rectal biopsies at varying stages of CWD progression, and the prevalence of CWD in free-ranging elk from Rocky Mountain National Park, Colorado, USA. We sampled and placed radio collars on 136 adult female elk in the winter of 2007-08. Elk with biopsy samples found positive for PrP(CWD) by immunohistochemistry (IHC) were euthanized and the obex and retropharyngeal lymph nodes were examined with IHC. We resampled, euthanized, and necropsied 20, 25, and 34 of the remaining study elk in each of the three following winters, respectively. Sensitivity of rectal biopsy samples increased in an asymptotic fashion with follicle count and was maximized at 85% (95% credible limits [CL]=60, 98) in the beginning of the study, when a greater proportion of elk were in a detectable stage of prion infection. However, maximum sensitivity was reduced to 72% (CL=46, 94) when we included resampled elk, which included recently infected elk that were initially negative using rectal biopsies and IHC. Test results were similar between rectal biopsies and the obex, but the earliest stages of prion infection were only detected by using retropharyngeal lymph nodes. Minimum CWD prevalence was estimated to be 9.9% (CL=5.7, 15.7) using rectal biopsies, but this rose to 12.9% (CL=8.0, 19.1) when we included four elk that were likely misdiagnosed at initial capture. Our results indicate rectal biopsies can provide a useful research tool for CWD in elk populations, but should be used with caution because they can miss individuals in early stages of infection and underestimate prevalence. Prevalence estimates from this population are the highest reported to date in elk and indicate that under appropriate conditions, CWD may be able to affect the dynamics of high-density elk populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568902     DOI: 10.7589/2011-12-362

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  21 in total

1.  Antemortem Detection of Chronic Wasting Disease Prions in Nasal Brush Collections and Rectal Biopsy Specimens from White-Tailed Deer by Real-Time Quaking-Induced Conversion.

Authors:  Nicholas J Haley; Chris Siepker; W David Walter; Bruce V Thomsen; Justin J Greenlee; Aaron D Lehmkuhl; Jürgen A Richt
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

2.  Pathogen-mediated selection in free-ranging elk populations infected by chronic wasting disease.

Authors:  Ryan J Monello; Nathan L Galloway; Jenny G Powers; Sally A Madsen-Bouterse; William H Edwards; Mary E Wood; Katherine I O'Rourke; Margaret A Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

3.  Chronic wasting disease management in ranched elk using rectal biopsy testing.

Authors:  Nicholas J Haley; Davin M Henderson; Sarah Wycoff; Joanne Tennant; Edward A Hoover; Dan Love; Ed Kline; Aaron Lehmkuhl; Bruce Thomsen
Journal:  Prion       Date:  2018-02-22       Impact factor: 3.931

4.  Ante-mortem detection of chronic wasting disease in recto-anal mucosa-associated lymphoid tissues from elk (Cervus elaphus nelsoni) using real-time quaking-induced conversion (RT-QuIC) assay: A blinded collaborative study.

Authors:  Sireesha Manne; Naveen Kondru; Tracy Nichols; Aaron Lehmkuhl; Bruce Thomsen; Rodger Main; Patrick Halbur; Somak Dutta; Anumantha G Kanthasamy
Journal:  Prion       Date:  2017-11-03       Impact factor: 3.931

5.  Seeded Amplification of Chronic Wasting Disease Prions in Nasal Brushings and Recto-anal Mucosa-Associated Lymphoid Tissues from Elk by Real-Time Quaking-Induced Conversion.

Authors:  Nicholas J Haley; Chris Siepker; Laura L Hoon-Hanks; Gordon Mitchell; W David Walter; Matteo Manca; Ryan J Monello; Jenny G Powers; Margaret A Wild; Edward A Hoover; Byron Caughey; Jürgen A Richt
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948

6.  Estimating chronic wasting disease susceptibility in cervids using real-time quaking-induced conversion.

Authors:  Nicholas J Haley; Rachel Rielinger; Kristen A Davenport; Katherine O'Rourke; Gordon Mitchell; Jürgen A Richt
Journal:  J Gen Virol       Date:  2017-10-23       Impact factor: 3.891

Review 7.  The ecology of chronic wasting disease in wildlife.

Authors:  Luis E Escobar; Sandra Pritzkow; Steven N Winter; Daniel A Grear; Megan S Kirchgessner; Ernesto Dominguez-Villegas; Gustavo Machado; A Townsend Peterson; Claudio Soto
Journal:  Biol Rev Camb Philos Soc       Date:  2019-11-21

8.  In utero transmission and tissue distribution of chronic wasting disease-associated prions in free-ranging Rocky Mountain elk.

Authors:  Anca Selariu; Jenny G Powers; Amy Nalls; Monica Brandhuber; Amber Mayfield; Stephenie Fullaway; Christy A Wyckoff; Wilfred Goldmann; Mark M Zabel; Margaret A Wild; Edward A Hoover; Candace K Mathiason
Journal:  J Gen Virol       Date:  2015-09-09       Impact factor: 3.891

9.  Prion-seeding activity in cerebrospinal fluid of deer with chronic wasting disease.

Authors:  Nicholas J Haley; Alexandra Van de Motter; Scott Carver; Davin Henderson; Kristen Davenport; Davis M Seelig; Candace Mathiason; Edward Hoover
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

Review 10.  Systematic review of management strategies to control chronic wasting disease in wild deer populations in North America.

Authors:  F D Uehlinger; A C Johnston; T K Bollinger; C L Waldner
Journal:  BMC Vet Res       Date:  2016-08-22       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.